Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis
- PMID: 35985543
- DOI: 10.1016/j.jhep.2022.07.025
Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
2022 International autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders.J Hepatol. 2023 Mar;78(3):e113-e114. doi: 10.1016/j.jhep.2022.09.026. Epub 2022 Oct 13. J Hepatol. 2023. PMID: 36243178 No abstract available.
Comment on
-
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.J Hepatol. 2022 Apr;76(4):841-849. doi: 10.1016/j.jhep.2021.12.041. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066089
-
2022 International Autoimmune Hepatitis Group non-response criteria in autoimmune hepatitis: A too early endpoint?J Hepatol. 2022 Nov;77(5):1461-1462. doi: 10.1016/j.jhep.2022.06.007. Epub 2022 Jun 16. J Hepatol. 2022. PMID: 35716845 No abstract available.
-
Rapid response predicts complete biochemical response and histological remission in autoimmune hepatitis.J Hepatol. 2022 Nov;77(5):1463-1464. doi: 10.1016/j.jhep.2022.07.012. Epub 2022 Jul 20. J Hepatol. 2022. PMID: 35870704 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
